Patrick Vallance was head of Head of R&D at GlaxoSmithKline until April 2018; from April 4th 2018 he will be Chief Scientific Adviser to the Government of the United Kingdom.
Vallance gained a BSc degree in 1981 from the University of London, qualified as a doctor in 1984, and was awarded his research MD in 1990. He was Professor of Medicine at UCL before joining GSK in 2006 as Head of Drug Discovery. In 2012 he became global head of R&D for GSK.
Under his leadership, GSK has developed new treatments for HIV, cancer, autoimmune diseases and asthma. His personal research in academia focused on vascular biology, studying the role of nitric oxide and endothelial cell physiology. He is a fellow of the Royal College of Physicians, was elected FMedSci in 1999 and FRS in 2017.